UPL Q1: consol loss narrows to ₹73 Cr, revenue +10% YoY as deleveraging cuts finance cost

UPL's consolidated Q1 FY27 revenue rose 10.5% YoY to ₹10,181 Cr (from ₹9,216 Cr), but the Group still posted a net loss of ₹73 Cr for the period — roughly half the ₹176 Cr loss a year ago. The composition matters: profit attributable to owners of the parent swung positive to ₹10 Cr from an ₹88 Cr loss, while the ₹83 Cr loss now sits with non-controlling interests. Basic EPS was ₹0.12. Sequentially revenue fell 44.5% from ₹18,335 Cr, but that is agrochemical seasonality (the Jan–Mar Rabi quarter is the year's strongest, Apr–Jun the weakest), not a slowdown; QoQ should not be read as the story here.

The swing to a narrower loss is led by deleveraging: finance costs dropped to ₹852 Cr from ₹1,007 Cr YoY (−15%), the clearest evidence the debt-reduction campaign we flagged pre-result is feeding through. Crop protection revenue grew 5.7% to ₹7,659 Cr and Seeds & Post-harvest 24.6% to ₹1,750 Cr; total segment EBIT was ₹1,110 Cr vs ₹985 Cr. One caveat on the loss-narrowing: other income carries a one-off ₹55 Cr Bombay High Court insurance arbitral award — strip it (the year-ago period had no equivalent) and the underlying loss is closer to ₹128 Cr, so the ~58% reported loss-narrowing overstates; the adjusted narrowing is nearer ~27%. Net margin improved (−0.7% vs −1.9% YoY) while operating margin held around 16%.

The stock went into the print at ₹621.45, up 2.3% over the past month of trading.

Against the bar we set in our preview — ₹11,700–12,100 Cr revenue and +14–18% EBITDA — the print missed: revenue landed 13–16% below and EBITDA was broadly flat, so management's own 14–18% EBITDA guidance was not met this quarter, though the 10–14% revenue-growth guide was met at its low end. Street had built the FY27 thesis on ~72% consolidated profit growth; a still-loss-making Q1 is a soft (if seasonally weakest) start. On the corporate front, the Composite Scheme of Arrangement (UPL SAS amalgamation, appointed date April 1, 2026) received BSE/NSE observation letters on July 29 but has no P&L effect yet, pending NCLT and shareholder approvals; the $1 Sustainable Tech acquisition and the Bioplanta stake divestment are immaterial. Standalone, revenue fell 15.8% YoY to ₹1,397 Cr with PAT of ₹89 Cr (vs ₹122 Cr) — the standalone entity is a small slice of the Group, so the consolidated picture governs.